Gui-rong L. Li
201 South Hubin Road
Xiamen, 361004, China
Xiamen, 361004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Corrigendum to "Angiotensin II upregulates KCa3.1 channels and stimulates cell proliferation in rat cardiac fibroblasts". [Biochem. Pharmacol. 85 (2013) 1486-1494].
Journal: Biochemical pharmacology
Published: February 14, 2026
Acacetin ameliorates cardiac hypertrophy by activating Sirt1/AMPK/PGC-1α pathway.
Journal: European journal of pharmacology
Published: October 19, 2021
Acacetin attenuates diabetes-induced cardiomyopathy by inhibiting oxidative stress and energy metabolism via PPAR-α/AMPK pathway.
Journal: European journal of pharmacology
Published: September 24, 2021
Acacetin suppresses the electrocardiographic and arrhythmic manifestations of the J wave syndromes.
Journal: PloS one
Published: June 29, 2020
Doxorubicin cardiomyopathy is ameliorated by acacetin via Sirt1-mediated activation of AMPK/Nrf2 signal molecules.
Journal: Journal of cellular and molecular medicine
Published: May 05, 2020
Regulation of the TRPC1 channel by endothelin-1 in human atrial myocytes.
Journal: Heart rhythm
Published: December 31, 2018
Comparative study of carvedilol and quinidine for inhibiting hKv4.3 channel stably expressed in HEK 293 cells.
Journal: European journal of pharmacology
Published: August 23, 2018
The Natural Flavone Acacetin Confers Cardiomyocyte Protection Against Hypoxia/Reoxygenation Injury via AMPK-Mediated Activation of Nrf2 Signaling Pathway.
Journal: Frontiers in pharmacology
Published: January 23, 2018
The Natural Flavone Acacetin Blocks Small Conductance Ca2+-Activated K+ Channels Stably Expressed in HEK 293 Cells.
Journal: Frontiers in pharmacology
Published: July 30, 2017
Bradykinin regulates cell growth and migration in cultured human cardiac c-Kit+ progenitor cells.
Journal: Oncotarget
Published: June 27, 2016
Tyrphostin AG556 increases the activity of large conductance Ca2+ -activated K+ channels by inhibiting epidermal growth factor receptor tyrosine kinase.
Journal: Journal of cellular and molecular medicine
Published: June 05, 2016
Last Updated: 09/26/2026